NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,802,333 | -5.8% | 518,382 | -6.9% | 0.04% | -4.3% |
Q2 2023 | $56,069,000 | +7.5% | 556,817 | -1.8% | 0.05% | +2.2% |
Q1 2023 | $52,147,237 | -17.9% | 566,741 | -22.2% | 0.04% | -22.4% |
Q4 2022 | $63,531,953 | +6.6% | 728,150 | -7.1% | 0.06% | -3.3% |
Q3 2022 | $59,600,000 | -7.6% | 784,118 | +2.8% | 0.06% | -4.8% |
Q2 2022 | $64,478,000 | -17.5% | 762,796 | -14.4% | 0.06% | -4.5% |
Q1 2022 | $78,174,000 | +6.4% | 890,881 | +6.1% | 0.07% | +11.9% |
Q4 2021 | $73,462,000 | +8.4% | 839,860 | +1.4% | 0.06% | -3.3% |
Q3 2021 | $67,743,000 | -10.4% | 828,353 | -0.0% | 0.06% | -11.6% |
Q2 2021 | $75,590,000 | -4.2% | 828,468 | -10.2% | 0.07% | -13.8% |
Q1 2021 | $78,880,000 | -31.8% | 922,781 | -24.7% | 0.08% | -37.0% |
Q4 2020 | $115,711,000 | +14.7% | 1,225,371 | +5.6% | 0.13% | +0.8% |
Q3 2020 | $100,880,000 | -9.9% | 1,160,088 | -9.5% | 0.13% | -16.0% |
Q2 2020 | $111,949,000 | +7.0% | 1,281,769 | +1.0% | 0.15% | -9.6% |
Q1 2020 | $104,665,000 | -8.4% | 1,269,450 | +5.1% | 0.17% | +14.5% |
Q4 2019 | $114,324,000 | +11.2% | 1,207,352 | +2.0% | 0.14% | +1.4% |
Q3 2019 | $102,820,000 | -31.2% | 1,183,198 | -27.8% | 0.14% | -33.8% |
Q2 2019 | $149,549,000 | -0.0% | 1,637,825 | +5.3% | 0.22% | -4.8% |
Q1 2019 | $149,551,000 | +15.1% | 1,555,554 | +2.7% | 0.23% | +0.4% |
Q4 2018 | $129,954,000 | +2.4% | 1,514,442 | +2.9% | 0.23% | +15.3% |
Q3 2018 | $126,865,000 | +55.8% | 1,472,439 | +36.6% | 0.20% | +43.1% |
Q2 2018 | $81,431,000 | -12.0% | 1,077,989 | -5.8% | 0.14% | -17.5% |
Q1 2018 | $92,521,000 | -3.4% | 1,144,346 | +0.3% | 0.17% | -5.7% |
Q4 2017 | $95,820,000 | +2.5% | 1,141,247 | +4.8% | 0.18% | -5.9% |
Q3 2017 | $93,471,000 | +0.2% | 1,088,773 | -2.5% | 0.19% | -7.4% |
Q2 2017 | $93,241,000 | -30.1% | 1,117,052 | -37.8% | 0.20% | -34.8% |
Q1 2017 | $133,400,000 | +16.6% | 1,796,145 | +14.3% | 0.31% | +6.2% |
Q4 2016 | $114,452,000 | +59.8% | 1,571,273 | +73.2% | 0.29% | +49.7% |
Q3 2016 | $71,629,000 | +36.0% | 907,151 | +42.1% | 0.20% | +18.2% |
Q2 2016 | $52,669,000 | +28.2% | 638,334 | +12.5% | 0.16% | +18.7% |
Q1 2016 | $41,098,000 | -14.2% | 567,343 | +1.9% | 0.14% | -18.7% |
Q4 2015 | $47,900,000 | -9.4% | 556,720 | -3.3% | 0.17% | -20.8% |
Q3 2015 | $52,897,000 | -4.3% | 575,469 | +2.3% | 0.22% | +1.9% |
Q2 2015 | $55,298,000 | +1.2% | 562,315 | +1.5% | 0.21% | -11.7% |
Q1 2015 | $54,648,000 | +21.2% | 554,186 | +13.9% | 0.24% | +9.1% |
Q4 2014 | $45,099,000 | +5.3% | 486,713 | +7.0% | 0.22% | -10.6% |
Q3 2014 | $42,828,000 | +11.5% | 454,984 | +7.2% | 0.25% | +3.8% |
Q2 2014 | $38,408,000 | +19.4% | 424,254 | +12.1% | 0.24% | +7.2% |
Q1 2014 | $32,175,000 | +14.1% | 378,438 | +7.9% | 0.22% | +4.7% |
Q4 2013 | $28,195,000 | +12.0% | 350,774 | +6.9% | 0.21% | -2.8% |
Q3 2013 | $25,170,000 | +13.3% | 328,114 | +4.5% | 0.22% | +3.3% |
Q2 2013 | $22,212,000 | – | 314,134 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |